Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. SPY
7. VRTS
8. NTAP
9. OLLI
10. NTSK

Go back to Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022
(NASDAQ: GMAB) Delayed: 34.41 +0.19 (0.56%)
Previous Close $34.22    52 Week High $ 
Open $34.63    52 Week Low $ 
Day High $34.66    P/E N/A 
Day Low $34.08    EPS $ 
Volume 890,949